What’s the Moral from CORAL?

November 18th, 2013

What’s the Moral from CORAL?

Richard A. Lange, MD, MBA and L. David Hillis, MD

The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study has shown that when added to a background optimal medical therapy, renal artery stenting provides no incremental benefit in people with atherosclerotic renal artery stenosis and either hypertension or chronic kidney disease. Specifically, renal artery stenting did not reduce the composite endpoint of death from cardiovascular or renal causes, MI, stroke, hospitalization for congestive heart failure, progressive renal insufficiency, or the need for dialysis. Further details are available in CardioExchange’s news coverage of CORAL.

Given these findings, should we stop screening for renal artery stenosis? Why or why not?

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

November 18th, 2013